Meta-analysis of Chromatin Programming by Steroid Receptors.

FOXA1 chromatin chromatin remodelers dynamic assisted loading pioneer factors steroid receptors transcription factors

Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
24 09 2019
Historique:
received: 15 05 2019
revised: 08 08 2019
accepted: 12 08 2019
entrez: 26 9 2019
pubmed: 26 9 2019
medline: 21 10 2020
Statut: ppublish

Résumé

Transcription factors (TFs) must access chromatin to bind to their response elements and regulate gene expression. A widely accepted model proposes that only a special subset of TFs, pioneer factors, can associate with condensed chromatin and initiate chromatin opening. We previously reported that steroid receptors (SRs), not considered pioneer factors, can assist the binding of an archetypal pioneer, the forkhead box protein 1 (FOXA1), at a subset of receptor-activated enhancers. These findings have been challenged recently, with the suggestion that newly acquired data fully support the prevailing pioneer model. Here, we reexamine our results and confirm the original conclusions. We also analyze and discuss a number of available datasets relevant to chromatin penetration by SRs and find a general consensus supporting our original observations. Hence, we propose that chromatin opening at some sites can be initiated by SRs, with a parallel recruitment of factors often treated as having a unique pioneer function. This Matters Arising paper is in response to Glont et al. (2019), published in Cell Reports.

Identifiants

pubmed: 31553919
pii: S2211-1247(19)31079-4
doi: 10.1016/j.celrep.2019.08.039
pmc: PMC6914262
mid: NIHMS1543787
pii:
doi:

Substances chimiques

Receptors, Steroid 0

Types de publication

Journal Article Meta-Analysis Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

3523-3534.e2

Subventions

Organisme : Intramural NIH HHS
ID : Z01 BC005450-25
Pays : United States

Informations de copyright

Published by Elsevier Inc.

Références

EMBO J. 2014 Feb 18;33(4):312-26
pubmed: 24451200
J Mol Biol. 2000 Aug 25;301(4):947-58
pubmed: 10966797
Mol Cell. 2015 Apr 2;58(1):21-34
pubmed: 25752574
Genome Biol. 2009;10(3):R25
pubmed: 19261174
Mol Cell Biol. 1991 Feb;11(2):688-98
pubmed: 1846670
Mol Syst Biol. 2011 Aug 30;7:526
pubmed: 21878914
Cell. 2008 Mar 21;132(6):958-70
pubmed: 18358809
EMBO J. 1987 Aug;6(8):2321-8
pubmed: 2822386
Genome Res. 2019 Aug;29(8):1223-1234
pubmed: 31337711
EMBO J. 2013 May 29;32(11):1568-83
pubmed: 23665916
Cold Spring Harb Symp Quant Biol. 1985;50:155-64
pubmed: 3868476
Nucleic Acids Res. 2015 Jan;43(2):848-61
pubmed: 25552417
Nat Genet. 2018 Feb;50(2):250-258
pubmed: 29358654
Genome Biol. 2014;15(12):550
pubmed: 25516281
Mol Cell. 2002 Feb;9(2):279-89
pubmed: 11864602
Cell. 1987 Dec 24;51(6):987-1000
pubmed: 3690668
EMBO J. 2011 Sep 13;30(19):3962-76
pubmed: 21915096
BMC Genomics. 2013 Jun 28;14:428
pubmed: 23805837
Nat Genet. 2006 Nov;38(11):1289-97
pubmed: 17013392
Mol Cell. 2013 Oct 10;52(1):25-36
pubmed: 24076218
Genome Biol. 2016 Feb 27;17:36
pubmed: 26922637
Nat Genet. 2011 Jan;43(1):27-33
pubmed: 21151129
Elife. 2017 Mar 13;6:
pubmed: 28287392
Nucleic Acids Res. 2017 Jan 25;45(2):619-630
pubmed: 27672034
Mol Cell. 2016 Apr 7;62(1):79-91
pubmed: 27058788
J Biol Chem. 2018 Sep 7;293(36):13795-13804
pubmed: 29507097
Cell. 2016 Apr 21;165(3):593-605
pubmed: 27062924
Nature. 2018 Oct;562(7725):76-81
pubmed: 30250250
Nature. 2012 Sep 6;489(7414):75-82
pubmed: 22955617
Cell. 2011 Aug 19;146(4):544-54
pubmed: 21835447
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
EMBO J. 1998 Jan 2;17(1):244-54
pubmed: 9427758
Nucleic Acids Res. 2018 Jan 9;46(1):203-214
pubmed: 29126175
Nat Rev Genet. 2019 Apr;20(4):207-220
pubmed: 30675018
Cell. 2005 Jul 15;122(1):33-43
pubmed: 16009131
Mol Cell. 2010 May 28;38(4):576-89
pubmed: 20513432
Elife. 2018 May 24;7:
pubmed: 29792595
Proc Natl Acad Sci U S A. 2016 Jul 19;113(29):8236-41
pubmed: 27382178
Cell Rep. 2019 Mar 5;26(10):2558-2565.e3
pubmed: 30840881
Nat Biotechnol. 2011 Jan;29(1):24-6
pubmed: 21221095
Cell. 2014 Oct 9;159(2):358-73
pubmed: 25303530
Cancer Res. 2013 Aug 15;73(16):5130-9
pubmed: 23803465
Mol Cell. 2016 Jun 2;62(5):665-7
pubmed: 27259199
Genes Dev. 2011 Nov 1;25(21):2227-41
pubmed: 22056668
Nature. 2018 Aug;560(7718):325-330
pubmed: 30089904
Endocr Rev. 2015 Aug;36(4):357-84
pubmed: 26052734
Curr Opin Chem Biol. 2008 Aug;12(4):418-26
pubmed: 18662801
Oncogene. 2014 Dec 11;33(50):5666-74
pubmed: 24292680
EMBO J. 1988 Oct;7(10):3073-9
pubmed: 2846275

Auteurs

Ville Paakinaho (V)

Institute of Biomedicine, University of Eastern Finland, Kuopio, 70211 Kuopio, Finland.

Erin E Swinstead (EE)

Laboratory of Receptor Biology and Gene Expression, National Cancer Institute, NIH, Bethesda, MD 20892-5055, USA.

Diego M Presman (DM)

Instituto de Fisiología, Biología Molecular y Neurociencias (IFIBYNE-UBA-CONICET), Universidad de Buenos Aires, Facultad de Ciencias Exactas y Naturales, Buenos Aires C1428EGA, Argentina.

Lars Grøntved (L)

Department of Biochemistry and Molecular Biology, University of Southern Denmark, 5230 Odense M, Denmark.

Gordon L Hager (GL)

Laboratory of Receptor Biology and Gene Expression, National Cancer Institute, NIH, Bethesda, MD 20892-5055, USA. Electronic address: hagerg@dce41.nci.nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH